Relationship of anti-C1q antibodies and anti-ENA antibodies with disease activity and nephric impairment in systemic lupus erythematosus
|更新时间:2025-01-15
|
Relationship of anti-C1q antibodies and anti-ENA antibodies with disease activity and nephric impairment in systemic lupus erythematosus
Journal of Army Medical UniversityVol. 33, Issue 20, Pages: 2128-2131(2011)
作者机构:
川北医学院:附属医院检验科,检验系2005级,检验系
作者简介:
基金信息:
DOI:
CLC:R593.241;R692;R392.11
Published:2011,
Published Online:30 October 2011,
稿件说明:
移动端阅览
FAN QUMING, LIU QIUYUE, ZHANG ZIXIA, et al. Relationship of anti-C1q antibodies and anti-ENA antibodies with disease activity and nephric impairment in systemic lupus erythematosus. [J]. Journal of army medical university, 2011, 33(20): 2128-2131.
DOI:
FAN QUMING, LIU QIUYUE, ZHANG ZIXIA, et al. Relationship of anti-C1q antibodies and anti-ENA antibodies with disease activity and nephric impairment in systemic lupus erythematosus. [J]. Journal of army medical university, 2011, 33(20): 2128-2131.DOI:
Relationship of anti-C1q antibodies and anti-ENA antibodies with disease activity and nephric impairment in systemic lupus erythematosus
ship of serum anti-C1q antibodies and anti-extractable nuclear antigen (anti-ENA) antibodies with disease activity and nephric impairment in systemic lupus erythematosus (SLE) for clinical values of the 2 antibodies in diagnosis and evaluation of the disease. Methods A total of 123 cases of SLE patients who admitted in our hospital in recent 1 year were divided into 4 groups according to SLE activity and lupus nephritis (LN)
that is
LN activity group (
n
=35); non-LN activity group(
n
=32); LN stable group (
n
=18) and non-LN stable group (
n
=38). Serum and urine specimens of SLE patients was collected within 24 h of first hospitalization. Anti-C1q antibodies were detected by ELISA
and anti-ENA antibodies were assayed by dot blotting. Dry chemistry method was used to detect urinary protein. β
2
-microglobulin (β
2
-MG) and creatinine (CREA) was assayed using the automatic biochemical analyzer. Results β
2
-MG positive rate in LN activity group (88.6%) was significantly higher than non-LN activity group(59.4%)and LN stable group(66.1%)(both
P
<
0.05)
and was still significantly higher than non-LN stable group(47.4%)(
P
<
0.01). The positive rate of CREA in stable group of LN (27.8%)was significantly higher than stable group of non-LN(0.0%)(
P
<
0.01). Urine protein characterized as “++++” positive rate in LN activity group(42.9%)was significantly higher than non-LN activity group(12.5%)and non-LN stable group(2.6%)(
P
<
0.05
0.01). Anti-C1q antibody positive rate was significantly higher in LN activity group (68.8%) than in non-LN stable group (36.8%)(
P
<
0.05). Significant differences were found in urinary protein as a “++++” and “+” positive rate in anti-C1q antibody-negative group and the anti-C1q antibody positive group (26.2%
vs
11.3%,14.8%
vs
38.7%,
P
<
0.05). Conclusion In SLE patients
nephric impairment occur when disease in activity
. Presence of anti-C1q antibodies and anti-ENA antibodies may aggravate the impairment. And to those patients
standard monitoring of anti-C1q antibodies and β
2
-MG is of significance to forecast the kidney damage.